Drugs / Lactobacillus casei Zhang
last change Jul 2024 re-read 2 minutes ago

Lactobacillus casei Zhang

Developed for
IgA glomerulonephritis
Investigated by
China Primary Health Care Foundation · Gang Xu

Trials 1 · a red edge is where a trial was stopped

202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT06528015 Jul 2024 → Dec 2026 expected IgA glomerulonephritis Gang Xu Not yet recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Lactobacillus casei Zhang “each bag added active probiotic Lactobacillus casei Zhang ≥100 billion CFU” NCT06528015